How Much Did Phylos Bioscience Raise?
Funding & Key Investors

Phylos Bioscience has secured significant enterprise-level funding, with a total capital infusion of $16M and a recent undisclosed amount of $0. This strategic financing underscores the company's pivotal role in advancing cannabis genomics and agricultural technology.

What is Phylos Bioscience?

Phylos Bioscience
Business ServicesResearch & Development

Phylos Bioscience stands as a global leader in cannabis genomics, leveraging advanced molecular genetics and computational biology. The company is dedicated to enhancing the development and performance of hemp and drug varieties across diverse agricultural settings. Through its world-class team, Phylos supports extensive research and development initiatives, fosters breeding partnerships with international collaborators, and provides comprehensive genetic testing solutions to cultivation businesses worldwide.

How much funding has Phylos Bioscience raised?

Phylos Bioscience has raised a total of $16M across 3 funding rounds:

2015

Private Equity

$1.4M

2022

Unspecified

$7.6M

2024

Debt

$7M

Private Equity (2015): $1.4M, investors not publicly disclosed

Unspecified (2022): $7.6M led by Accomplice, Merida Capital Holdings, and Entourage Effect Capital

Debt (2024): $7M supported by OrganiGram

Key Investors in Phylos Bioscience

Accomplice

Accomplice is an early-stage venture capital firm known for investing in disruptive technology companies, likely focusing on deep tech and innovative solutions.

Merida Capital Holdings

Merida Capital Holdings is a private equity firm that invests in the cannabis industry, focusing on companies that offer ancillary services and products within the sector.

Entourage Effect Capital

Entourage Effect Capital is a venture capital firm that invests in the cannabis ecosystem, supporting businesses across cultivation, processing, and retail.

What's next for Phylos Bioscience?

The substantial enterprise-level investment positions Phylos Bioscience for accelerated growth and innovation in the rapidly evolving cannabis industry. This backing is expected to fuel further advancements in their genetic testing solutions and expand their global reach in research, development, and cultivation support. The company's focus on optimizing plant performance through cutting-edge genomics suggests a strategic expansion into new markets and a deepening of its existing partnerships, solidifying its leadership in agricultural biotechnology.

See full Phylos Bioscience company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesHuman Resources Management Systems (HRMS)
Business ServicesGraphicsArchitecture, Engineering & DesignConstructionConstruction Management
Business ServicesDocument ManagementCommercial Printing
Business ServicesSoftware TestingProject Management

Frequently Asked Questions Regarding Phylos Bioscience Financial Insights

What are the most recent funding rounds that Phylos Bioscience has completed, and what were the funding rounds?
Phylos Bioscience has recently completed 3 funding rounds: Debt on Jul 23, 2024, Unspecified on Feb 1, 2022, Private Equity on Aug 30, 2015.
What is the total amount of funding Phylos Bioscience has raised to date?
Phylos Bioscience has raised a total of $16M in funding to date.
How many funding rounds has Phylos Bioscience completed?
Phylos Bioscience has completed 3 funding rounds.
How much funding did Phylos Bioscience raise in its most recent funding round?
Phylos Bioscience raised $7M in its most recent funding round.
Who are the lead investors in Phylos Bioscience's latest funding round?
The lead investor in Phylos Bioscience's latest funding round was OrganiGram. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Phylos Bioscience's history?
The largest funding round in Phylos Bioscience's history was $7.6M.
See more information about Phylos Bioscience